Stacie C Summers

Dr. Stacie C Summers


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2024 in Pets
Verified
Journal Article
Open access
PDF file
MPMarianne Pan
Marianne Pan
TATodd Archer
Todd Archer
AMANDREW MACKIN
ANDREW MACKIN
RWRobert Wills
Robert Wills
LNLakshmi Narayanan
Lakshmi Narayanan
SSStacie C Summers
Stacie C Summers
The administration of modified cyclosporine with food has been reported to decrease oral bioavailability. The objective of this study was to compare the pharmacodynamic effects of oral modified cyclosporine in healthy dogs when administered with and without food. In this randomized, crossover study, eight client-owned dogs received a commercial formulation of modified cyclosporine (median dose, 3.5 mg/kg PO q12h) with food (fed phase) or one hour before food (fasted phase) for 7 days. Two hour post capsule administration was used as the expected time of peak cyclosporine concentration. Peak cyclosporine blood concentration measured by antibody-conjugated magnetic immunoassay and interleukin-2 (IL-2) mRNA expression assessed by quantitative reverse transcription PCR (qRT-PCR) were measured at baseline, seventh day of each phase, and after a 21-day washout. Three dogs were withdrawn due to refractory anorexia. For the five dogs that completed this study, no difference in cytokine expression (p = 0.9) was found when comparing qRT-PCR values between the fed and fasted phase. All dogs achieved post-treatment IL-2 expression corresponding with “moderate” levels of immunosuppression or higher after both phases. No difference in peak blood cyclosporine concentration was found between the 7th day of the fed phase (median, 2042; range, 1484–2100 ng/mL) and fasted phase (median, 1990; range 1137–2100 ng/mL; p = 0.8). Feeding dogs at the time of the administration of oral modified cyclosporine can achieve similar suppression of IL-2 expression and blood concentrations two hours post drug administration as compared to when the drug is administered without food.